Amanote Research
Register
Sign In
Engineering of a VPAC2 Receptor Peptide Agonist to Impart Dipeptidyl Peptidase IV Stability and Enhance in Vivo Glucose Disposal
doi 10.1021/jm0609059.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Wound Healing Process and Dipeptidyl Peptidase IV
Medicina fluminensis
A Potent and Highly Selective VPAC2 Agonist Enhances Glucose-Induced Insulin Release and Glucose Disposal: A Potential Therapy for Type 2 Diabetes
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Discovery of Dipeptidyl-Peptidase IV—a 40 Year Journey From Bench to Patient
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Distribution of Dipeptidyl Peptidase IV in Patients With Chronic Tonsillitis
Clinical and Vaccine Immunology
Medicine
Immunology
Allergy
Clinical Biochemistry
Microbiology
Discovery of Food-Derived Dipeptidyl Peptidase IV Inhibitory Peptides: A Review
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Design and Discovery of a Novel Dipeptidyl-Peptidase IV (CD26)-Based Prodrug Approach
Glucagon-Like Peptide-1 (GLP-1) Mediates the Protective Effects of Dipeptidyl Peptidase IV Inhibition on Pulmonary Hypertension
Journal of Biomedical Science
Cell Biology
Pharmacology
Biochemistry
Endocrinology
Clinical Biochemistry
Molecular Biology
Medicine
Metabolism
Diabetes
Pyrazolidine Derivatives With Heteroaryl Urea as Dipeptidyl Peptidase IV Inhibitors
Chemical and Pharmaceutical Bulletin
Medicine
Drug Discovery
Chemistry
Dipeptidyl Peptidase IV and Incident Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
